Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Change in Receivables (2017 - 2025)

Sensus Healthcare has reported Change in Receivables over the past 9 years, most recently at -$3.3 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$3.3 million for Q4 2025, down 218.95% from a year ago — trailing twelve months through Dec 2025 was -$13.6 million (down 248.18% YoY), and the annual figure for FY2025 was -$13.6 million, down 248.18%.
  • Change in Receivables for Q4 2025 was -$3.3 million at Sensus Healthcare, down from -$3.2 million in the prior quarter.
  • Over the last five years, Change in Receivables for SRTS hit a ceiling of $10.0 million in Q4 2022 and a floor of -$8.1 million in Q4 2021.
  • Median Change in Receivables over the past 5 years was -$1.5 million (2024), compared with a mean of -$710100.0.
  • Peak annual rise in Change in Receivables hit 667.86% in 2022, while the deepest fall reached 671.57% in 2022.
  • Sensus Healthcare's Change in Receivables stood at -$8.1 million in 2021, then soared by 223.45% to $10.0 million in 2022, then tumbled by 62.56% to $3.8 million in 2023, then fell by 26.37% to $2.8 million in 2024, then plummeted by 218.95% to -$3.3 million in 2025.
  • The last three reported values for Change in Receivables were -$3.3 million (Q4 2025), -$3.2 million (Q3 2025), and -$5.4 million (Q2 2025) per Business Quant data.